Replies to post #228304 on Biotech Values

[bladerunner1717]

re: CCXI

Whalatane,

The doctor who got me into CCXI also thought the JPM presentation was exceptional. I still have two-thirds of my original position (cost basis: $7). I had/have a ton. I talked to the doc today and he expects this to go to $80.

I'll ask him about the companies that you mentioned, FREQ & RAPT.

Bladerunner

[Bickema]

CCXI - if only every biotech company had a CEO as well spoken and enthusiastic as ChemoCentryx's

that was the most impressive presentation i've ever heard.

"great cash position, $205 million. enough cash on hand to take us through all the data readouts the NDA, submission and the PDUFA date"

"...and that is the landscape of golden opportunity"